- Country: Ukraine
- Summary: Code Dk 021: 2015 33600000-6 Pharmaceutical Products (Mnn: Aloe, Atorvastatin, Bilastine, Bromhexine, Vinpocetine, Vitamin B1 in Combination with Vitamin B6 And/Or Vitamin B12, Comb Drug, Comb.
- UAT Ref No: 123570284
- Deadline: 08 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 888532.8
- Notice Type: Tender
- Document Ref. No.: UA-2025-07-29-010229-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Code DK 021: 2015 33600000-6 Pharmaceutical Products (MNN: ALOE, ATORVastatin, Bilastine, Bromhexine, Vinpocetine, Vitamin B1 in Combination with Vitamin B6 and/OR Vitamin B12, Comb. Pranobex, Silymarin, Macrogol, Thioctic Acid, GlimePiride, Domperidone, Rosuvastatin, Etoricoxib, Captopril and diuretics, Barbiturates in combination with other drugs, Mono, Meldonium, Nebivolol, Nicotinic acid, Nimesulide, Octreotide, Myramistin, Papaverine, Pentoxifylline, Perindopril, Perindopril and diuretics, Piracetam, Platyphylline, Acetylcysteine, Meloxicam, Inosine, Rimantadine, Thiomine (Vit B1), Valsartan, UrsodeoxyCholic Acid, Famotidine, Mometasone)
Type of purchase: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Aloe Extract Liquid-Darnitsa, liquid extract for injection, 1 ml of extract contains aloe dry extract (Aloes Extractum siccum) in terms The content of calcium salts and magnesium organic acids in the dry matter - 2.25 mg, 1 ml in ampoule, 5 ampoules in contour cellular packaging, 2 contour cellular packaging in a pack. 3 blisters in a pack of cardboard., Biolagis, tablets, 20 mg, 10 tablets in blister; 1 blister in a pack., Bromhexin-Darnitsa, tablets, 8 mg, 20 tablets in contour cellular packaging., Vinpocetin-Darnitsa, concentrate for preparation of infusion solution, 5 mg/ml, 2 ml in ampoule; 5 ampoules in contour cellular packaging; 2 contour cellular packaging in a pack;, Vinpocetin-Darnitsa, tablets, 5 mg, 10 tablets in contour cellular packaging; 3 contour cells in a pack., Witxon(r), solution for injection, 1 ml of solution contains: thiamine hydrochloride 50 mg, pyridoxine hydrochloride 50 mg, cyaniablamine 0.5 mg, 2 ml in the ampoule; 5 ampoules in blister; 1 Blister in a pack of cardboard labeled in Ukrainian., Witxon(r), tablets covered with film sheath, 1 tablet contains benftyamin 100 mg of 100 % dry substance, pyridoxine hydrochloride 100 mg in terms substance, 10 tablets in blister; 6 blisters in a pack with a car ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCode Dk 021: 2015 33600000-6 Pharmaceutical Products (Mnn: Aloe, Atorvastatin, Bilastine, Bromhexine, Vinpocetine, Vitamin B1 in Combination with Vitamin B6 And/Or Vitamin B12, Comb Drug, Comb. - Ukraine Tender
The ODESSA MILITARY MEDICAL CLINICAL CENTER (CLINICAL HOSPITAL) OF THE STATE BORDER GUARD SERVICE OF UKRAINE (MILITARY UNIT 2524), a Government sector organization in Ukraine, has announced a new tender for Code Dk 021: 2015 33600000-6 Pharmaceutical Products (Mnn: Aloe, Atorvastatin, Bilastine, Bromhexine, Vinpocetine, Vitamin B1 in Combination with Vitamin B6 And/Or Vitamin B12, Comb Drug, Comb.. This tender is published on UkraineTenders under UAT Ref No: 123570284 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-08.
The estimated tender value is UAH 888532.8, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
